Matches in Wikidata for { <http://www.wikidata.org/entity/Q64599153> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q64599153 description "clinical trial" @default.
- Q64599153 description "ensayu clínicu" @default.
- Q64599153 description "klinisch onderzoek" @default.
- Q64599153 description "клінічне випробування" @default.
- Q64599153 name "A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q64599153 type Item @default.
- Q64599153 label "A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q64599153 prefLabel "A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)" @default.
- Q64599153 P1132 Q64599153-EE97EFC2-A321-4EFA-84EA-5193C66DC656 @default.
- Q64599153 P1476 Q64599153-CF0AFCD7-CDBA-4917-96A3-A8E17E256900 @default.
- Q64599153 P17 Q64599153-0834206F-480A-4664-88A9-D4896EEEF8CE @default.
- Q64599153 P17 Q64599153-140C792F-2F86-40BC-82F9-54302BA29341 @default.
- Q64599153 P17 Q64599153-801C1E05-A15A-4307-8230-BBD15B14DE7F @default.
- Q64599153 P17 Q64599153-8544C92C-8150-4879-89C8-FC90188F7A75 @default.
- Q64599153 P17 Q64599153-D5C69119-E5AE-43E3-9679-9D72A15A69B6 @default.
- Q64599153 P17 Q64599153-DF257A91-4EE1-41A9-BDF0-988C429E3712 @default.
- Q64599153 P2899 Q64599153-645C63D2-DED9-4C9B-BC47-10C0C19DDCE0 @default.
- Q64599153 P3098 Q64599153-8DB21B1C-10AC-4649-B3A9-ECF849A1DFD5 @default.
- Q64599153 P31 Q64599153-4AE61F66-553B-4B2D-9405-02661A133921 @default.
- Q64599153 P580 Q64599153-FC505FFA-E65D-478D-B0DA-875AE601217D @default.
- Q64599153 P582 Q64599153-AF622EF7-AD0E-4544-809D-A9C56DE2E098 @default.
- Q64599153 P6099 Q64599153-8B2B2AF0-A7AB-461B-AB1D-FF742FA90FAF @default.
- Q64599153 P6153 Q64599153-4A01FF95-9000-4F37-8C88-23CB99121765 @default.
- Q64599153 P6153 Q64599153-5479CD87-BC51-438B-8BBA-88674E06081A @default.
- Q64599153 P6153 Q64599153-966AEBD6-FEC5-4F06-B178-D7B64DD047E5 @default.
- Q64599153 P6153 Q64599153-B34F504D-970E-4EAF-A6D4-1F2CF95603E8 @default.
- Q64599153 P6153 Q64599153-EF1052AE-F356-4096-8AD9-F30516A1B1D0 @default.
- Q64599153 P8363 Q64599153-4ABD2608-7DC1-4A7A-B5B9-F0F0194BBEEA @default.
- Q64599153 P859 Q64599153-A10BB86F-3C22-4AE1-9586-70554C89FB75 @default.
- Q64599153 P1132 "+49" @default.
- Q64599153 P1476 "A Phase 2, Multicenter, Single-Arm Study of Trastuzumab Emtansine in Patients With HER2 IHC-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Received At Least One Prior Chemotherapy Regimen" @default.
- Q64599153 P17 Q183 @default.
- Q64599153 P17 Q29 @default.
- Q64599153 P17 Q30 @default.
- Q64599153 P17 Q36 @default.
- Q64599153 P17 Q38 @default.
- Q64599153 P17 Q39 @default.
- Q64599153 P2899 "+18" @default.
- Q64599153 P3098 "NCT02289833" @default.
- Q64599153 P31 Q30612 @default.
- Q64599153 P580 "2014-12-15T00:00:00Z" @default.
- Q64599153 P582 "2016-10-25T00:00:00Z" @default.
- Q64599153 P6099 Q42824440 @default.
- Q64599153 P6153 Q1535116 @default.
- Q64599153 P6153 Q192334 @default.
- Q64599153 P6153 Q219563 @default.
- Q64599153 P6153 Q4403855 @default.
- Q64599153 P6153 Q5529378 @default.
- Q64599153 P8363 Q78089383 @default.
- Q64599153 P859 Q212646 @default.